Stockreport

Appendix 4C – Q2 FY25 Quarterly Cash Flow Report

Alterity Therapeutics Limited - American Depositary Shares  (ATHE) 
PDF Highlights Topline data for ATH434-201 randomized, double-blind Phase 2 clinical trial on track for expected release by early February 2025ATH434-201 trial in early-sta [Read more]